Robert J. Kammer, Director at Imprimis Pharmaceuticals, Inc. (IMMY), sold 130,000 shares at $3.00 ($390K) on 2018-08-10, disclosed to the SEC on 2018-08-15.
Open-market sale of $390k IMMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HROW | SELL | 2019-09-11 | $37K | — | Filing → |
| HROW | SELL | 2019-08-14 | $45K | — | Filing → |
| HROW | SELL | 2019-07-16 | $51K | — | Filing → |